Skip to main content
logo
NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0101
-0.0499 (-83.17%)
Jul 30, 2026, 3:42 PM EST

NKGen Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.080.43
Revenue Growth
----81.92%-
Gross Profit
---0.060.4
Operating Income
-24.01-26.97-29.75-24.35-21.86
Net Income
-23.55-44.29-82.95-26.75-23.27
Earnings Per Share
-1.23-1.54-5.38-4.21-1.63
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.110.030.120.35
Total Debt
38.1952.9119.9212.0351.97
Net Cash (Debt)
-38.19-52.8-19.9-11.92-51.62
Net Cash Growth
-----
Net Cash Per Share
-1.10-1.83-1.29-1.87-3.62

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.65-20.88-21.95-22.56-19.55
Capital Expenditures
----0.1-0.4
Free Cash Flow
-19.65-20.88-21.95-22.66-19.95
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---76.62%92.96%
Operating Margin
----31618.18%-5131.69%
Pretax Margin
----34736.36%-5460.09%
Profit Margin
----34745.46%-5461.27%
FCF Margin
----29425.97%-4683.33%